Today: 19 June 2026
Browse Category

XETRA:XFAB 27 May 2026

Stock Market Today

  • Bitcoin Traders Increase Bearish Bets as Price Slides to $52,000
    June 19, 2026, 4:04 AM EDT. Bitcoin faces pressure as traders increase bearish bets amid a hawkish U.S. Federal Reserve that strengthens the dollar. Bitcoin exchange-traded funds (ETFs) are experiencing continuous outflows, while Strategy, the largest publicly listed bitcoin holder, confronts challenges with its preferred stock STRC plunging below $100 par value. This decline undermines Strategy's bitcoin accumulation plan. Arca CIO Jeff Dorman warns Strategy must sell bitcoin (BTC) and MicroStrategy (MSTR) shares to stabilize STRC or risk further capital structure erosion. BTC prices hovered near $62,400, down 0.8% from midnight UTC, after reaching $67,000 earlier this week, reflecting heightened market uncertainty.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 19.06.2026

19 June 2026
LIVEMarkets rolling coverageStarted: June 19, 2026, 4:00 AM EDTUpdated: June 19, 2026, 4:08 AM EDT Bitcoin Traders Increase Bearish Bets as Price Slides to $52,000 June 19, 2026, 4:04 AM EDT. Bitcoin faces pressure as traders increase bearish bets amid a hawkish U.S. Federal Reserve that strengthens the dollar. Bitcoin exchange-traded funds (ETFs) are experiencing continuous outflows, while Strategy, the largest publicly listed bitcoin holder, confronts challenges with its preferred stock STRC plunging below $100 par value. This decline undermines Strategy’s bitcoin accumulation plan. Arca CIO Jeff Dorman warns Strategy must sell bitcoin (BTC) and MicroStrategy (MSTR) shares to stabilize
Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop